Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q2 2025 · 10-Q
Revenue$382.46M$382.46M+13.2% vs Q2 2024 Net Income$32.58M$32.58M−8.8% vs Q2 2024 EPS Diluted$0.54$0.54−11.5% vs Q2 2024 Gross Profit$184,487,000+14.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Operating Cash Flowderived$83,307,000+21.6% Free Cash Flowderived$69,556,000+20.2% Margins · derivedGross margin48.2%+0.6 pt vs Q2 2024
Operating margin12.3%−1.3 pt vs Q2 2024
Net margin8.5%−2.1 pt vs Q2 2024
ended Jun 30, 2025 · filed Jul 30, 2025 · 30 d after period end